Oral administration of dextromethorphan prevents the development of morphine tolerance and dependence in rats

Pain

Volumn 67, Issue 2-3, 1996, Pages 361-368

  Mao, Jianren ^a   Price, Donald D ^a   Caruso, Frank S ^b   Mayer, David J ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Algos Pharmaceutical Corporation   (United States)

Author keywords

analgesia; dependence; dextromethorphan; morphine; tolerance

Indexed keywords

DEXTROMETHORPHAN; MORPHINE SULFATE;

ANALGESIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINOCICEPTION; ARTICLE; CONTROLLED STUDY; DRUG DEPENDENCE; DRUG EFFECT; DRUG TOLERANCE; NONHUMAN; PAIN; PRIORITY JOURNAL; RAT;

EID: 0030273192     PISSN: 03043959     EISSN: None     Source Type: Journal    
DOI: 10.1016/0304-3959(96)03120-X     Document Type: Article

References (40)

1. Albers, G.W., Goldberg, M.P. and Choi, D.W., N-Methyl-D-aspartate antagonists: ready for clinical trial in brain ischemia? Ann. Neurol., 25 (1989) 398-403.
2. Albers, G.W., Saenz, R.E., Moses, J.A. and Choi, D.W., Safety and tolerance of oral dextromethorphan in patients at risk for brain ischemia, Stroke, 22 (1991) 1075-1077.
3. Albers, G.W., Saenz, R.E. and Moses, J.A., Tolerability of oral dextromethorphan in patients with a history of brain ischemia, Clin. Neuropharmacol., 15 (1992) 509-514.
4. Bem, J.L. and Peck, R. Dextromethorphan: an overview of safety issues, Drug Safety, 7 (1992) 190-199.
5. Ben Eliyahu, S., Marek, P., Vaccarino, A.L., Mogil, J.S., Sternberg, W.F. and Liebeskind, J.C., The NMDA receptor antagonist MK-801 prevents long-lasting non-associative morphine tolerance in the rat, Brain Res., 575 (1992) 304-308.
6. Chen, Y. and Yu, L., Differential regulation by cAMP-dependent protein kinase and protein kinase C of the μ opioid receptor coupling to a G protein activated K channel, J. Biol. Chem., 269 (1994) 7839-7842.
7. Choi, D.W., Dextrorphan and dextromethorphan attenuate glutamate neurotoxicity, Brain Res., 403 (1987) 333-336.
8. D'Amour, F.E. and Smith, D.L., A method for determining loss of pain sensation, J. Pharmacol. Exp. Ther., 72 (1941) 74-79.
9. G-nitro-L-arginine, attenuate analgesic tolerance to the mu-opioid morphine but not to kappa opioids. Pain, 56 (1994a) 69-75.
10. Elliott, K.J., Hynansky, A. and Inturrisi, C.E., Dextromethorphan attenuates and reverses morphine tolerance, Pain, 59 (1994b) 361-368.
11. Ferkany, J.W., Borosky, S.A., Clissold, D.B. and Pontecorvo, M.J., Dextromethorphan inhibits NMDA-induced convulsions, Eur. J. Pharmacol., 151 (1988) 151-154.
12. George, C.P., Goldberg, M.P., Choi, D.W. and Steinberg, G.K., Dextromethorphan reduces neocortical ischemic neuronal damage in vivo, Brain Res., 440 (1988) 375-379.
13. Hollander, D., Pradas, J., Kaplan, R., Mcleod, H.L., Evans, W.E. and Munsat, T.L., High-dose dextromethorphan in amyotrophic lateral sclerosis: phase I safety and pharmacokinetic studies, Ann. Neurol., 36 (1994) 920-924.
14. Jurna, I., Kaiser, R., Kretz, O. and Baldauf, J., Oral naloxone reduces constipation but not antinociception from oral morphine in the rat, Neurosci. Lett., 142 (1992) 62-64.
15. Kellstein, D.E. and Mayer, D.J., Spinal co-administration of cholecystokinin antagonists with morphine prevents the development of opioid tolerance, Pain, 47 (1991) 221-229.
16. Kolesnikov, Y.A., Pick, C.G., Ciszewska, G. and Pasternak, G.W., Blockade of tolerance to morphine but not to k opioids by a nitric oxide synthase inhibitor, Proc. Natl. Acad. Sci. USA, 90 (1993) 5162-5166.
17. Koyuncuoglu, H. and Saydam, B., The treatment of heroin addicts with dextromethorphan: a double-blind comparison of dextromethorphan and chlorpromazine, Int. J. Clin. Pharmacol. Ther. Toxicol., 28 (1990) 147-152.
18. Leander, J.D., Evaluation of dextromethorphan and carbetapentane as anticonvulsants and N-methyl-D-aspartic acid antagonists in mice, Epilepsy Res., 4 (1989) 28-33.
19. Litchfield, J.T. and Wilcoxon, F., A simplified method of evaluating dose-effect experiments, J. Pharmacol. Exp. Ther., 96 (1949) 99-102.
20. Mao, J., Price, D.D., Hayes, R.L., Lu, J., Mayer, D.J. and Frenk, H., Intrathecal treatment with dextrorphan or ketamine potently reduces pain-related behaviors in a rat model of peripheral mononeuropathy, Brain Res., 605 (1993) 164-168.
21. Mao, J., Price, D.D. and Mayer, D.J. Thermal hyperalgesia in association with the development of morphine tolerance in rats: roles of excitatory amino acid receptors and protein kinase C. J. Neurosci., 14 (1994) 2301-2312.
22. Mao, J., Price, D.D. and Mayer, D.J., Mechanisms of hyperalgesia and opiate tolerance: a current view of their possible interactions, Pain, 62 (1995) 259-274.
23. Marek, P., Ben Eliyahu, S., Gold, M. and Liebeskind, J.C., Excitatory amino acid antagonists (kynurenic acid and MK-801) attenuate the development of morphine tolerance in the rat. Brain Res., 547 (1991a) 77-81.
24. Marek, P., Ben Eliyahu, S., Vaccarino, A.L. and Liebeskind, J.C. Delayed application of MK-801 attenuates development of morphine tolerance in rats, Brain Res., 558 (1991b) 163-165.
25. Mayer, D.J., Wolfle, T.L., Akil, H., Carder, B. and Liebeskind, J.C. Analgesia from electrical stimulation in the brainstem of the rat, Science, 174 (1971) 1351-1354.
26. Mayer, D.J., Mao, J. and Price, D.D., The development of morphine tolerance is associated with increase in membrane-bound protein kinase C: prevention by GM1 ganglioside, Soc. Neurosci. Abstr., 19 (1993) 1796.
27. Mayer, D.J., Mao, J. and Price, D.D., The development of morphine tolerance and dependence is associated with translocation of protein kinase C, Pain, 61 (1995) 365-374.
28. Mestek, A., Hurley, J.H., Bye, L.S., Campbell, A.D., Chen, Y., Tian, M., Liu, J., Schulman, H. and Yu, L., The human μ opioid receptor: modulation of functional desensitization by calcium/calmodulin-dependent protein kinase and protein kinase C. J. Neurosci., 15 (1995) 2396-2406.
29. Olney, J.W., Labruyere, J., Gang, G., Wozniak, D.F., Price, M.T. and Sesma, M.A., NMDA antagonist neurotoxicity: mechanism and prevention, Science, 254 (1991) 1515-1518.
30. Paronis, C.A. and Holtzman, S.G. Increased analgesic potency of mu agonists after continuous naloxone infusion in rats. J. Pharmacol. Exp. Ther., 259 (1991) 582-589.
31. Price, D.D., Mao, J., Frenk, H. and Mayer, D.J., The N-methyl-D-aspartate receptor antagonist dextromethorphan selectively reduces temporal summation of second pain in man, Pain, 59 (1994) 165-174.
32. Schmitt, B., Netzer, R., Fanconi, S., Baumann, P. and Boltshauser, E., Drug refractory epilepsy in brain damage: effect of dextromethorphan on EEG in four patients, J. Neurol. Neurosurg. Psychiatry, 57 (1994) 333-339.
33. Sparenborg, S., Brennecke L.H. and Braitman, D.J., Prevention of somata neurotoxicity by non-opioid antitussives, Neurotoxicology, 11 (1990) 509-520.
34. Steinberg, G.K., George, C.P., DeLaPaz, R., Shibata, D.K. and Gross, T., Dextromethorphan protects against cerebral injury following transient focal ischemia in rabbits, Stroke, 19 (1988) 1112-1118.
35. Tal, M. and Bennett, G.J., Dextrorphan relieves neuropathic heat-evoked hyperalgesia in the rat. Neurosci. Lett., 151 (1993) 107-110.
36. Tanganelli, S., Antonelli, T., Morari, M., Bianchi, C. and Beani, L., Glutamate antagonists prevent morphine withdrawal in mice and guinea pigs, Neurosci. Lett., 122 (1991) 270-272.
37. Tiseo, P.J. and Inturrisi, C.E., Attenuation and reversal of morphine tolerance by the competitive N-methyl-D-aspartate receptor antagonist, LY274614. J. Pharmacol. Exp. Ther., 264 (1993) 1090-1096.
38. Tortella, F.C., Pellicano, M. and Bowery, N.G., Dextromethorphan and neuromodulation: old drug coughs up new activities, Trends Pharmacol. Sci., 10 (1989) 501-507.
39. Trujillo, K.A. and Akil, H., Inhibition of morphine tolerance and dependence by the NMDA receptor antagonist MK-801, Science, 251 (1991) 85-87.
40. Wong, B.Y., Coulter, D.A., Choi, D.W. and Prince, D.A., Dextrorphan and dextromethorphan, common antitussives, are antiepileptic and antagonize N-methyl-D-aspartate in brain slices, Neurosci. Lett., 85 (1988) 261-266.